Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""COLLE J"" wg kryterium: Autor


Tytuł:
Proactive Recruitment Strategy for Patient Identification for Lung Cancer Screening.
Autorzy:
Thuppal S; Division of Cardiothoracic Surgery, Department of Surgery, Southern Illinois School of Medicine, Springfield, Illinois.; Center for Clinical Research, Illinois University School of Medicine, Springfield, Illinois.
Hendren JR; Division of Cardiothoracic Surgery, Department of Surgery, Southern Illinois School of Medicine, Springfield, Illinois.
Colle J; Division of Cardiothoracic Surgery, Department of Surgery, Southern Illinois School of Medicine, Springfield, Illinois.
Sapra A; Department of Family and Community Medicine, Southern Illinois University School of Medicine, Springfield, Illinois.
Bhandari P; Department of Family and Community Medicine, Southern Illinois University School of Medicine, Springfield, Illinois.
Rahman R; Department of Family and Community Medicine, Southern Illinois University School of Medicine, Springfield, Illinois.
Krus-Johnston A; Department of Family and Community Medicine, Southern Illinois University School of Medicine, Springfield, Illinois.
Hoffman MR; Department of Family and Community Medicine, Southern Illinois University School of Medicine, Springfield, Illinois.
Foray N; Department of Pulmonology, Southern Illinois University School of Medicine, Springfield, Illinois.
Hazelrigg S; Division of Cardiothoracic Surgery, Department of Surgery, Southern Illinois School of Medicine, Springfield, Illinois.
Crabtree T; Division of Cardiothoracic Surgery, Department of Surgery, Southern Illinois School of Medicine, Springfield, Illinois .
Pokaż więcej
Źródło:
Annals of family medicine [Ann Fam Med] 2023 Mar-Apr; Vol. 21 (2), pp. 119-124.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Lung Neoplasms*/diagnostic imaging
Humans ; Smoking ; Early Detection of Cancer/methods ; Retrospective Studies ; Prospective Studies ; Family Practice ; Mass Screening
Czasopismo naukowe
Tytuł:
Impact of Molecular Biology in Diagnosis, Prognosis, and Therapeutic Management of BCR::ABL1 -Negative Myeloproliferative Neoplasm.
Autorzy:
Abbou N; Molecular Biology Laboratory, North University Hospital, 13015 Marseille, France.; INSERM, INRAE, C2VN, Aix-Marseille University, 13005 Marseille, France.
Piazzola P; Hematology and Cellular Therapy Department, Conception University Hospital, 13005 Marseille, France.
Gabert J; Molecular Biology Laboratory, North University Hospital, 13015 Marseille, France.; INSERM, INRAE, C2VN, Aix-Marseille University, 13005 Marseille, France.
Ernest V; Hematology Laboratory, Timone University Hospital, 13005 Marseille, France.
Arcani R; INSERM, INRAE, C2VN, Aix-Marseille University, 13005 Marseille, France.; Department of Internal Medicine, Timone University Hospital, 13005 Marseille, France.
Couderc AL; Department of Geriatrics, South University Hospital, 13005 Marseille, France.
Tichadou A; Hematology and Cellular Therapy Department, Conception University Hospital, 13005 Marseille, France.
Roche P; Hematology and Cellular Therapy Department, Conception University Hospital, 13005 Marseille, France.
Farnault L; Hematology and Cellular Therapy Department, Conception University Hospital, 13005 Marseille, France.
Colle J; INSERM, INRAE, C2VN, Aix-Marseille University, 13005 Marseille, France.; Hematology and Cellular Therapy Department, Conception University Hospital, 13005 Marseille, France.
Ouafik L; CNRS, INP, Institute of Neurophysiopathol, Aix-Marseille Université, 13005 Marseille, France.; APHM, CHU Nord, Service d'Onco-Biologie, Aix-Marseille Université, 13005 Marseille, France.
Morange P; INSERM, INRAE, C2VN, Aix-Marseille University, 13005 Marseille, France.; Hematology Laboratory, Timone University Hospital, 13005 Marseille, France.
Costello R; INSERM, INRAE, C2VN, Aix-Marseille University, 13005 Marseille, France.; Hematology and Cellular Therapy Department, Conception University Hospital, 13005 Marseille, France.; TAGC, INSERM, UMR1090, Aix-Marseille University, 13005 Marseille, France.
Venton G; INSERM, INRAE, C2VN, Aix-Marseille University, 13005 Marseille, France.; Hematology and Cellular Therapy Department, Conception University Hospital, 13005 Marseille, France.; TAGC, INSERM, UMR1090, Aix-Marseille University, 13005 Marseille, France.
Pokaż więcej
Źródło:
Cells [Cells] 2022 Dec 27; Vol. 12 (1). Date of Electronic Publication: 2022 Dec 27.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Myeloproliferative Disorders*/diagnosis
Myeloproliferative Disorders*/genetics
Myeloproliferative Disorders*/therapy
Polycythemia Vera*/genetics
Thrombocythemia, Essential*/genetics
Humans ; Calreticulin/genetics ; Calreticulin/metabolism ; Molecular Biology ; Receptors, Thrombopoietin/genetics ; Receptors, Thrombopoietin/metabolism
Czasopismo naukowe
Tytuł:
A rare case of pleural localisation of both metastatic Merkel cell carcinoma and chronic lymphocytic leukaemia.
Autorzy:
Kaspi E; Aix Marseille Univ, APHM, INSERM, MMG, Hôpital la Timone, Service de Biologie Cellulaire, Marseille, France.
Fritz S; AP-HM, CHU La Conception, Hematology and Vascular Biology Laboratory, Marseille, France.
Colle J; Aix Marseille Univ, APHM, INSERM, TAGC, La Conception, Hematology and Cellular Therapy Department, Marseille, France.
Amatore F; Aix Marseille Univ, APHM, Timone Hospital, Dermatology and Oncodermatology Department, Marseille, France.
Frankel D; Aix Marseille Univ, APHM, INSERM, MMG, Hôpital la Timone, Service de Biologie Cellulaire, Marseille, France.
Roll P; Aix Marseille Univ, APHM, INSERM, MMG, Hôpital la Timone, Service de Biologie Cellulaire, Marseille, France.
Pokaż więcej
Źródło:
Cytopathology : official journal of the British Society for Clinical Cytology [Cytopathology] 2021 May; Vol. 32 (3), pp. 367-370. Date of Electronic Publication: 2020 Dec 20.
Typ publikacji:
Case Reports
MeSH Terms:
Carcinoma, Merkel Cell/*diagnosis
Carcinoma, Merkel Cell/*pathology
Leukemia, Lymphocytic, Chronic, B-Cell/*diagnosis
Leukemia, Lymphocytic, Chronic, B-Cell/*pathology
Pleura/*pathology
Aged ; Female ; Humans ; Skin Neoplasms/diagnosis ; Skin Neoplasms/pathology
Raport
Tytuł:
Could daratumumab induce the maturation of plasmablasts in Plasmablastic lymphoma?-Potential therapeutic applications.
Autorzy:
Roché P; Hematology and Cellular Therapy Department, La Conception, University Hospital of Marseille, AP-HM, Marseille, France.
Venton G; Hematology and Cellular Therapy Department, La Conception, University Hospital of Marseille, AP-HM, Marseille, France.
Berda-Haddad Y; Hematology and Vascular Biology Laboratory, La Conception, University Hospital of Marseille, AP-HM, Marseille, France.
Fritz S; Hematology and Vascular Biology Laboratory, La Conception, University Hospital of Marseille, AP-HM, Marseille, France.
Ivanov V; Hematology and Cellular Therapy Department, La Conception, University Hospital of Marseille, AP-HM, Marseille, France.
Mercier C; Hematology and Cellular Therapy Department, La Conception, University Hospital of Marseille, AP-HM, Marseille, France.
Colle J; Hematology and Cellular Therapy Department, La Conception, University Hospital of Marseille, AP-HM, Marseille, France.
Tichadou A; Hematology and Cellular Therapy Department, La Conception, University Hospital of Marseille, AP-HM, Marseille, France.
Fanciullino R; Pharmacy Unit, La Conception,, University Hospital of Marseille, AP-HM, Marseille, France.
Lepidi H; Department of Pathology, La Timone Hospital, AP-HM, Marseille, France.
Costello R; Hematology and Cellular Therapy Department, La Conception, University Hospital of Marseille, AP-HM, Marseille, France.
Farnault L; Hematology and Cellular Therapy Department, La Conception, University Hospital of Marseille, AP-HM, Marseille, France.
Pokaż więcej
Źródło:
European journal of haematology [Eur J Haematol] 2021 Apr; Vol. 106 (4), pp. 589-592. Date of Electronic Publication: 2021 Feb 02.
Typ publikacji:
Letter
MeSH Terms:
Antibodies, Monoclonal/*pharmacology
Antineoplastic Agents, Immunological/*pharmacology
Cell Differentiation/*drug effects
Plasma Cells/*drug effects
Plasma Cells/*pathology
Plasmablastic Lymphoma/*pathology
Antibodies, Monoclonal/therapeutic use ; Antineoplastic Agents, Immunological/therapeutic use ; Humans ; Molecular Targeted Therapy ; Plasmablastic Lymphoma/drug therapy
Opinia redakcyjna
Tytuł:
Different sensitivity of CD19-positive bone marrow and lymph node lymphoblasts may cause resistance to blinatumomab in relapsed B-cell acute lymphoblastic leukemia/lymphoma.
Autorzy:
Ivanov V; Department of Hematology, La Conception, University Hospital of Marseille, Marseille, France.
Farnault L; Department of Hematology, La Conception, University Hospital of Marseille, Marseille, France.
Mercier C; Department of Hematology, La Conception, University Hospital of Marseille, Marseille, France.
Colavolpe C; Department of Nuclear Medicine, La Timone & North University Hospital, Aix-Marseille University, Marseille, France.
Venton G; Department of Hematology, La Conception, University Hospital of Marseille, Marseille, France.; INSERM, Marseille, France.
Colle J; Department of Hematology, La Conception, University Hospital of Marseille, Marseille, France.
Lepidi H; Department of Pathology, CHU La Conception, AP-HM, Marseille, France.
Arnoux I; Department of Hematology, CHU La Timone, AP-HM, Marseille, France.
Nicolino-Brunet C; Department of Hematology and Vascular Biology, CHU La Conception, AP-HM, Marseille, France.
Berda-Haddad Y; Department of Hematology and Vascular Biology, CHU La Conception, AP-HM, Marseille, France.
Fanciullino R; Pharmacy Unit, La Conception, University Hospital of Marseille, APHM, Marseille, France.; SMARTc Unit, Pharmacokinetics Laboratory, Marseille, France.
Ivanov G; Surrey and Sussex NHS Trust, Redhill, UK.
Costello R; Department of Hematology, La Conception, University Hospital of Marseille, Marseille, France.; INSERM, Marseille, France.
Pokaż więcej
Źródło:
Leukemia & lymphoma [Leuk Lymphoma] 2020 May; Vol. 61 (5), pp. 1230-1233. Date of Electronic Publication: 2020 Jan 03.
Typ publikacji:
Letter
MeSH Terms:
Antibodies, Bispecific*/therapeutic use
Antineoplastic Agents*/therapeutic use
Lymphoma*
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma*/diagnosis
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma*/drug therapy
Precursor Cell Lymphoblastic Leukemia-Lymphoma*/drug therapy
Antigens, CD19 ; B-Lymphocytes ; Bone Marrow ; Humans ; Lymph Nodes
Opinia redakcyjna

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies